PRQR vs ISPR Comparison

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded and non-branded vaping hardware products in both the nicotine and cannabis spaces, as well as the assembly of nicotine pouch products and other next-generation nicotine products. The company sells its e-cigarette and pouch products globally, in markets where it is legally permitted to do so. The majority of its nicotine products are marketed under the Aspire brand name, and the cannabis products are marketed under the Ispire brand name. Geographically, the company generates the majority of its revenue from Europe, followed by North America, Asia Pacific, and other markets.